Neuroprotection by urate on 6-OHDA-lesioned rat model of Parkinson's disease: linking to Akt/GSK3β signaling pathway.
about
Neuroprotective effects of urate are mediated by augmenting astrocytic glutathione synthesis and releaseA review of the clinical evidence for complementary and alternative therapies in Parkinson's disease.Brain region mapping using global metabolomics.Ependymal cells of the mouse brain express urate transporter 1 (URAT1)Nrf2 signaling contributes to the neuroprotective effects of urate against 6-OHDA toxicity.Protection by inosine in a cellular model of Parkinson's diseaseComplementary & alternative management of Parkinson's disease: an evidence-based review of eastern influenced practices.Inosine to increase serum and cerebrospinal fluid urate in Parkinson disease: a randomized clinical trial.Activation of GSK-3β and caspase-3 occurs in Nigral dopamine neurons during the development of apoptosis activated by a striatal injection of 6-hydroxydopamineSerum uric acid levels in patients with Alzheimer's disease: a meta-analysis.Gout and the risk of Alzheimer's disease: a population-based, BMI-matched cohort study.Disrupted and transgenic urate oxidase alter urate and dopaminergic neurodegenerationPurines: forgotten mediators in traumatic brain injury.Impairment of Atg5-dependent autophagic flux promotes paraquat- and MPP⁺-induced apoptosis but not rotenone or 6-hydroxydopamine toxicityUrate Levels Predict Survival in ALS: Analysis of the Expanded PRO-ACT Database.Intranasal Administration of GDNF Protects Against Neural Apoptosis in a Rat Model of Parkinson's Disease Through PI3K/Akt/GSK3β Pathway.Current and experimental treatments of Parkinson disease: A guide for neuroscientists.Urate as a Marker of Risk and Progression of Neurodegenerative Disease.Low serum uric acid levels in progressive supranuclear palsy.Oral Inosine Persistently Elevates Plasma antioxidant capacity in Parkinson's disease.Brief isoflurane anesthesia regulates striatal AKT-GSK3β signaling and ameliorates motor deficits in a rat model of early-stage Parkinson's disease.Immunohistochemical and in situ hybridization study of urate transporters GLUT9/URATv1, ABCG2, and URAT1 in the murine brain.Neurotoxin mechanisms and processes relevant to Parkinson's disease: an update.Genetic variability related to serum uric acid concentration and risk of Parkinson's disease.Metabolic Differences between Dogs of Different Body Sizes.Manganese and the Insulin-IGF Signaling Network in Huntington's Disease and Other Neurodegenerative Disorders.Zingerone activates VMAT2 during MPP(+) -induced Cell Death.Antioxidant status of serum bilirubin and uric acid in patients with polymyositis and dermatomyositis.Genome-wide variant by serum urate interaction in Parkinson's disease.Lower Serum Bilirubin and Uric Acid Concentrations in Patients with Parkinson's Disease in China.Elevation of striatal urate in experimental models of Parkinson's disease: a compensatory mechanism triggered by dopaminergic nigrostriatal degeneration?Glut9-mediated Urate Uptake Is Responsible for Its Protective Effects on Dopaminergic Neurons in Parkinson's Disease Models.Microarray Analysis of the Molecular Mechanism Involved in Parkinson's Disease.Urate inhibits microglia activation to protect neurons in an LPS-induced model of Parkinson's disease.Recent Advances in Biomarkers for Parkinson's Disease
P2860
Q28393646-40F7CFE5-90A0-44EE-B3FA-CAD1796F83F3Q30365907-A89DF82C-6288-4904-BD38-78AF81E12BDFQ30873368-A97BB2BF-8B7A-4C2F-85D8-B0188A245EC9Q33589859-1BD49323-5B12-449E-8981-2C4C9529BC59Q33800053-11A26D78-4328-409F-8275-219EF5DC588BQ33998724-3634ECB6-4969-4C2A-AA02-91A2D1516C15Q34423275-DC72E91E-8A37-40B5-A42D-EA46ECC7846EQ34658560-BE1911CC-352E-4411-8320-5454C1027B53Q34936413-A68ABD4B-F336-4D76-8C5E-8321371D0A3FQ35143061-E240E8F3-4CE0-439B-B36B-16F2BF801F21Q36029745-D283B625-431F-4271-912D-57E13A61FCDDQ36512151-F18940CB-8605-49F5-860B-8C8EA5589C01Q36788533-FBCA8DEC-D6DF-4132-86A1-9C9786144371Q37312661-A9805DE2-5ACB-45EE-B517-D5A6151A00CAQ38600633-10207E5A-3BC0-4C99-8AA1-A4B33D2DACAAQ38714411-960D51D2-D79A-4CEA-BBC1-AA4550A76C4AQ38941557-F4FEF0F8-A317-48E7-9D3A-85BF081663CDQ39044143-A5A3CD6F-5AE0-4CF4-A943-5782D50F440FQ40190481-180E11B1-FC5B-433D-8157-449386C95FC6Q40954387-F33488A6-4B53-4AA9-B137-73199C4DFF24Q41551976-797C6A0A-CA2E-41CF-8959-F4CD3FAD4E9DQ42247910-E2048064-1275-422E-ADAF-D9A7AB985392Q43679571-6B488F6C-4A81-45C7-B804-1B34C7F89A4DQ45980386-6CFEAE1F-2005-472D-9750-3BDA4F69667AQ46026460-30207FA1-2C24-4144-8053-CB44C401B6EAQ46309597-AB5B3B83-00CB-4864-802E-DD88E8A91EAEQ46683287-8475E3A7-5AAE-404A-B3D5-6763AF75024AQ48031533-65EE5E80-88CB-46D0-98BA-81A5A5AFA2A7Q48075588-62FBD7A2-5839-40AF-9D2F-8008D1E3E15BQ48435711-6ABEA0F7-074F-49F3-81B4-204D3BCC8631Q48681641-22AF783B-997E-4EE6-A7F1-B49F0B2D4ACCQ49698299-7BE8359B-B0E5-4F2D-AE8E-8D19C53D139DQ54979603-9CD0E235-E2FA-48A1-B89A-2E08F657C512Q55230759-F863CF81-35F4-48E2-A4EE-B83BFBA717ECQ58572579-FDB25029-CC43-41CD-8113-62B1D16B0FD2
P2860
Neuroprotection by urate on 6-OHDA-lesioned rat model of Parkinson's disease: linking to Akt/GSK3β signaling pathway.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Neuroprotection by urate on 6- ...... o Akt/GSK3β signaling pathway.
@en
Neuroprotection by urate on 6- ...... o Akt/GSK3β signaling pathway.
@nl
type
label
Neuroprotection by urate on 6- ...... o Akt/GSK3β signaling pathway.
@en
Neuroprotection by urate on 6- ...... o Akt/GSK3β signaling pathway.
@nl
prefLabel
Neuroprotection by urate on 6- ...... o Akt/GSK3β signaling pathway.
@en
Neuroprotection by urate on 6- ...... o Akt/GSK3β signaling pathway.
@nl
P2093
P2860
P356
P1476
Neuroprotection by urate on 6- ...... o Akt/GSK3β signaling pathway.
@en
P2093
Li-Fang Hu
Ning Zhang
Ping-Wei Di
Qi-Lin Zhang
Tingting Huang
Wei-Feng Luo
Wen-Yan Hua
Yi-Xian Huang
P2860
P304
P356
10.1111/JNC.12038
P407
P577
2012-10-25T00:00:00Z